Reminder for Regeneron Investors: March 10 Deadline Approaches for Joining Class Action Lawsuit
NEW YORK — Rosen Law Firm, a prominent legal entity specializing in investor rights, has issued a reminder to those who acquired securities from Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) during the period from November 2, 2023, to October 30, 2024. Investors are instructed to take note of a crucial upcoming deadline on March 10, 2025, for the appointment of the lead plaintiff in a class-action lawsuit concerning alleged securities fraud. Investors who have purchased shares within this defined window, referred to as the Class Period, can potentially partake in compensation arrangements on a contingency basis. … Read more